Related references
Note: Only part of the references are listed.Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Marco Mielcarek et al.
BLOOD (2009)
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
Afonso C. Vigorito et al.
BLOOD (2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
Advances in the selection of HLA-compatible donors: Refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry
Stephen Spellman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia
Theresa Hahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival
Mary Eapen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease
Yukimi Sakoda et al.
BLOOD (2007)
Prediction of graft-versus-host disease in humans by donor gene-expression profiling
Chantal Baron et al.
PLOS MEDICINE (2007)
Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy:: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy
Ibrahim Yakoub-Agha et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens
Wendy M. Leisenring et al.
BLOOD (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials
M al-Jurf et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
PJ Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Chronic graft-versus-host disease
SJ Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
SJ Lee et al.
BLOOD (2002)
Peripheral blood stem cell versus bone marrow allotransplantation:: does the source of hematopoietic stem cells matter?
M Körbling et al.
BLOOD (2001)
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
C Kollman et al.
BLOOD (2001)
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis
C Cutler et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
